As the toy makers gather in Berlin for ATTD to display their toys there’s lots of news flow this week. So, let’s have it.
This morning Novo Nordisk and Abbott announced a partnership which according to a press release;
“Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLink mobile app and LibreView cloud-based system). The partnership reflects both companies' commitment to make diabetes management easier . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.